Bafna Pharmaceuticals Ltd (BAFNAPH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 852453, "name": "Bafna Pharma.", "stock_name": "Bafna Pharma.", "full_name": "Bafna Pharmaceuticals Ltd", "name_url": "stocks-analysis/bafna-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "154.80", "chg": 7.35, "chgp": "4.98%", "dir": 1, "prev_price": "147.45", "mcapval": "366.00 Cr", "mcap": "Micro Cap", "scripcode": 532989, "symbol": "BAFNAPH", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE878I01022", "curr_date": "Jun 03, 03:30 PM", "curr_time": "04:15 AM", "last_traded_at": "Jun 03, 03:30 PM IST", "bse_nse_vol": "6.18 k", "exc_status": "Active", "traded_date": "Jun 03, 2026", "traded_date_str": "2026 06 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bafna-pharma-852453-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Above All Moving Averages and Now at Upper Circuit: Bafna Pharmaceuticals Ltd Gains 5.0% in a Single Session", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-momentum-4033514", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_upper_circuit_4033514.png", "date": "2026-06-03 10:00:31", "description": "At Rs 152.68, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 3 Jun 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Bafna Pharmaceuticals Ltd Valuation Shifts Signal Price Attractiveness Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-valuation-shifts-signal-price-attractiveness-challenges-4032754", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_valuationdot_4032754.png", "date": "2026-06-03 08:01:25", "description": "Bafna Pharmaceuticals Ltd has experienced a notable shift in its valuation parameters, moving from a fair to an expensive rating, raising questions about its price attractiveness relative to historical levels and peer benchmarks. Despite a recent 4.98% intraday gain, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest investors should carefully reassess its market positioning within the Pharmaceuticals & Biotechnology sector." }, { "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-momentum-4030429", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_upper_circuit_4030429.png", "date": "2026-06-02 10:00:28", "description": "At Rs 145.41, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5% on 2 Jun 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5.09% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4026118", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_upper_circuit_4026118.png", "date": "2026-06-01 10:00:36", "description": "At Rs 138.49, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.09% on 1 Jun 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Bafna Pharmaceuticals Declines 3.11% Amid Mixed Signals and Technical Optimism", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-declines-311-amid-mixed-signals-and-technical-optimism-4023063", "imagepath": "", "date": "2026-05-30 14:07:16", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Technical upgrade to Sell rating despite flat financials</p>\n <p><strong>27 May:</strong> Upper circuit hit amid strong buying pressure</p>\n <p><strong>27 May:</strong> Valuation reclassified from expensive to fair</p>\n <p><strong>29 May:</strong> Week closes at Rs.134.00 (-3.11%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.138.30</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.134.00</div><div class=\"sta..." }, { "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4016763", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BafnaPharmaceut_stocks_hitting_upper_circuit_4016763.png", "date": "2026-05-27 11:00:12", "description": "At Rs 136.66, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5% on 27 May 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Bafna Pharmaceuticals Ltd Valuation Shifts to Fair Amid Mixed Market Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-valuation-shifts-to-fair-amid-mixed-market-performance-4015611", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BafnaPharmaceut_valuationdot_4015611.png", "date": "2026-05-27 08:01:18", "description": "Bafna Pharmaceuticals Ltd has recently undergone a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This transition, coupled with a downgrade in its overall Mojo Grade from Strong Sell to Sell, reflects evolving market perceptions amid fluctuating financial metrics and sector dynamics. This article delves into the valuation changes, peer comparisons, and the stock’s price attractiveness in the context of its historical performance and broader market trends." }, { "title": "Bafna Pharmaceuticals Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-upgraded-to-sell-on-technical-improvements-despite-flat-financials-4013037", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BafnaPharmaceut_mojoScore_4013037.png", "date": "2026-05-26 09:02:37", "description": "Bafna Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 25 May 2026, driven primarily by a shift in technical indicators despite continued flat financial performance. The company’s micro-cap status and weak fundamental metrics continue to weigh on its valuation, but recent technical trends have improved, prompting a reassessment of its market stance." }, { "title": "When is the next results date for Bafna Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bafna-pharmaceuticals-ltd-4007412", "imagepath": "", "date": "2026-05-22 23:20:21", "description": "The next results date for Bafna Pharmaceuticals Ltd is scheduled for 29 May 2026...." } ], "total": 321, "sid": "852453", "stock_news_url": "https://www.marketsmojo.com/news/bafna-pharmaceuticals-852453" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "01-Jun-2026", "details": "Newspaper Publication for the Audited Financial Results of the Company for the Quarter & Year ended March 31 2026 as published in Financial Express and Makkal Kural on May 31 2026.", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On May 29 2026", "datetime": "29-May-2026", "details": "We hereby inform you that the Board of Directors in their meeting held on May 29 2026 inter-alia considered and approved the Audited Financial Results of the Company along with the Auditors Report issued by the Statutory Auditors of the Company for the Quarter and Year ended March 31 2026.", "source": "BSE" }, { "caption": "Audited Financial Results For Quarter And Year Ended March 31 2026", "datetime": "29-May-2026", "details": "We herewith enclose the Audited Financial Results of the Company along with the Statutory Auditors Report for the Quarter and Year ended March 31 2026 as approved by the Board of Directors of the Company at its meeting held on May 29 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13", "dt": "2013-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Technical upgrade to Sell rating despite flat financials

27 May: Upper circuit hit amid strong buying pressure

27 May: Valuation reclassified from expensive to fair

29 May: Week closes at Rs.134.00 (-3.11%)

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-05-27 11:00:12

At Rs 136.66, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5% on 27 May 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Bafna Pharmaceuticals Ltd Valuation Shifts to Fair Amid Mixed Market Performance

2026-05-27 08:01:18

Bafna Pharmaceuticals Ltd has recently undergone a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This transition, coupled with a downgrade in its overall Mojo Grade from Strong Sell to Sell, reflects evolving market perceptions amid fluctuating financial metrics and sector dynamics. This article delves into the valuation changes, peer comparisons, and the stock’s price attractiveness in the context of its historical performance and broader market trends.

Read full news article

Bafna Pharmaceuticals Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials

2026-05-26 09:02:37

Bafna Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 25 May 2026, driven primarily by a shift in technical indicators despite continued flat financial performance. The company’s micro-cap status and weak fundamental metrics continue to weigh on its valuation, but recent technical trends have improved, prompting a reassessment of its market stance.

Read full news article

When is the next results date for Bafna Pharmaceuticals Ltd?

2026-05-22 23:20:21

The next results date for Bafna Pharmaceuticals Ltd is scheduled for 29 May 2026....

Read full news article